Retrospective Cataract Surgery Outcomes

This study was approved by the Institutional Review Board of Saneikai Tsukazaki Hospital (Approval No. 211014), and the procedures followed were in accordance with the 1975 Declaration of Helsinki and its later amendments. This retrospective study included patients who underwent a cataract operation at Saneikai Tsukazaki Hospital between August 2009 and October 2020. Subjects were selected from among patients with no ocular diseases other than cataract, who developed no ocular complications intra- or postoperatively and who had no after cataract postoperatively. Overall, 1318 eyes of 785 patients were implanted with SN60WF J-code (SN60WF-J), 2490 eyes of 1420 patients were implanted with either SN60WF Q-code or A-code (SN60WF-Q,A), 1418 eyes of 816 patients were implanted with ZCB00, and 3717 eyes of 2098 patients were implanted with ZCB00V.
SN60WF-J was implanted from August 2009 to December 2011. SN60WF Q-code was implanted from January 2012 to May 2016, and SN60WF A-code was implanted from June 2016 to October 2020. ZCB00 was implanted throughout the investigation period, whereas ZCB00V was implanted from January 2013 to October 2020 (Figure 1).